10:00 AM EDT, 06/25/2024 (MT Newswires) -- T2 Biosystems ( TTOO ) said Tuesday it has signed an exclusive distribution deal for its T2Dx Instrument and test panels for Hong Kong and Macau.

Under the agreement, T2 Biosystems ( TTOO ) will sell its T2Dx Instrument, T2Bacteria Panel, T2Candida Panel, and T2Resistance Panel through an unnamed new distributor to expand its commercialization in the Asia Pacific region.

Introducing the T2Dx Instrument and sepsis panels in Hong Kong and Macau is expected to enable rapid detection of sepsis-causing pathogens and antibiotic resistance genes there, allowing faster targeted therapy, the company said.

Price: 6.73, Change: +0.18, Percent Change: +2.75